Target intelligence / Profile preview

Mitochondrial ribosome-associated GTPase 2 (MTG2)

Target
MTG2
Molecular classification
Enzyme, GTPase, Ribosome assembly factor, Other
01

Overview

Mitochondrial ribosome-associated GTPase 2 (MTG2), also known as GTPBP5, is a mitochondrial Obg-family GTPase essential for the late stages of large mitochondrial ribosomal subunit (mtLSU) assembly[1][2]. MTG2 functions as a molecular switch, regulating critical mitochondrial processes including ribosome biogenesis and protein synthesis[1][2]. It directly interacts with 16S rRNA and specific ribosomal proteins and plays a checkpoint role by coordinating with assembly factors to ensure only mature ribosomal subunits become part of the active ribosome[1]. Loss of MTG2 impairs mitochondrial protein synthesis and overall energy metabolism, with pathological consequences in high-energy tissues[2]. MTG2 is evolutionarily conserved and specifically associated with mitochondria, operating as a peripheral protein of the inner mitochondrial membrane[3]. Key points: - MTG2 is not considered a primary therapeutic target (such as a receptor, transporter, or typical drug target) in current literature; its dysfunction has pathogenic consequences, but no drugs or direct modulators are reported[1][2]. - Main role: Late-stage assembly and maturation of the mitochondrial large ribosomal subunit, crucial for mitochondrial protein synthesis and energy production[1][2][3]. - Pathology: Mutations or dysfunction in MTG2 can contribute to mitochondrial diseases, especially those affecting energy-demanding organs[2]. - Family/Classification: Belongs to the Obg family of GTPases, classified enzymatically as a GTPase and as a mitochondrial ribosome assembly factor[1][2][3]. If you require fields such as interacting drugs, mechanism of action, biomarkers, or safety concerns specifically for drug development, current sources do not report them for MTG2. The gene's disruption affects mitochondrial function, but it is not an established drug target at present[1][2][3].

Other names
GTPBP5Protein obg homolog 1OBGH1ObgH1dJ1005F21.2FLJ10741mitochondrial ribosome-associated GTPase 2GTP-binding protein 5
02

Biological functions

Mitochondrial ribosome assemblyProtein synthesisMitochondrial translationCellular energy metabolism
03

Disease associations

Other (Mitochondrial dysfunction-related diseases, potentially impacting energy-demanding tissues such as muscle and brain)[2]

Beyond the preview

Go deeper on Mitochondrial ribosome-associated GTPase 2 (MTG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosome-associated GTPase 2 (MTG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call